Autobio Diagnostics Co

Autobio Diagnostics Co CROIC

The Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co (603658.SS) as of Oct 16, 2026 is 8.26 %. In the previous year, Cash Return on Invested Capital (CROIC) was 7.27 % — a change of 13.62% (higher).

CROIC

8.26 %

YoY

13.62%

Last updated:

Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co is 2025 8.26 % . Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co was 2024 7.27 % . It decreases by 13.62% higher compared to the previous year.

The Autobio Diagnostics Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
12.02 CNY
Jan 1, 2019
2.41 CNY
Jan 1, 2020
-1.81 CNY
Jan 1, 2021
5.26 CNY
Jan 1, 2022
7.83 CNY
Jan 1, 2023
6.40 CNY
Jan 1, 2024
7.27 CNY
Jan 1, 2025
8.26 CNY
The Autobio Diagnostics Co CROIC history
YEARCROICYoY
8.26 %+13.62%
7.27 %+13.68%
6.40 %-18.36%
7.83 %+48.86%
5.26 %-391.24%
-1.81 %-174.95%
2.41 %-79.95%
12.02 %+672.30%
1.56 %-85.64%
10.85 %+1.72%
10.66 %-26.84%
14.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Autobio Diagnostics Co Stock analysis

What does Autobio Diagnostics Co do? Autobio Diagnostics Co Ltd, listed on the Shanghai Stock Exchange under ticker 603658.SS, is a healthcare company based in Zhengzhou, China. The company specializes in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. With a workforce of 5,505 employees, Autobio Diagnostics went public on September 1, 2016. Its product portfolio includes immunodiagnostic reagents such as microplate chemiluminescence diagnostic reagents, enzyme-linked immunosorbent assay (ELISA) diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The company also offers microbiology detection products, including training detection reagents, susceptibility detection reagents, and rapid detection reagents. Device products encompass microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. Autobio Diagnostics primarily serves domestic markets within China, focusing on providing diagnostic solutions for healthcare applications. The company's headquarters is located in Zhengzhou, Henan Province, and it operates within the healthcare sector, specifically in the health care industry. Its website, https://www.autobio.com.cn/, provides further information on its services and products. Autobio Diagnostics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Autobio Diagnostics Co stock

Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co is 8.26 % in 2025.

Cash Return on Invested Capital (CROIC) of Autobio Diagnostics Co changed from 7.27 % to 8.26 %, representing a 13.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Autobio Diagnostics Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Autobio Diagnostics Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Autobio Diagnostics Co

All Key Metrics — Autobio Diagnostics Co